Complete Blood Cell Count-Derived Inflammatory Biomarkers in Early-Stage Non-Small-Cell Lung Cancer

Background: Complete blood cell count (CBC)-derived inflammatory biomarkers are widely used as prognostic parameters for various malignancies, but the best predictive biomarker for early-stage non-small-cell lung cancer (NSCLC) is unclear. We retrospectively analyzed early-stage NSCLC patients to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Fumihiro, Kozuma, Yuka, Toyokawa, Gouji, Yamazaki, Koji, Takeo, Sadanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Editorial Committee of Annals of Thoracic and Cardiovascular Surgery 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641888/
https://www.ncbi.nlm.nih.gov/pubmed/32074540
http://dx.doi.org/10.5761/atcs.oa.19-00315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641888/
https://www.ncbi.nlm.nih.gov/pubmed/32074540
http://dx.doi.org/10.5761/atcs.oa.19-00315

Ejemplares similares